Ephb4-related lymphatic-related hydrops fetalis is a rare genetic condition that causes severe fluid buildup in a developing baby before birth. It is usually recognized during pregnancy or at birth, and common features can include widespread swelling, extra fluid around the lungs or heart, and skin edema. Not everyone will have the same experience. The condition can be life-threatening, especially when the fluid buildup is severe, but the outlook varies from one baby to another. Treatment focuses on careful monitoring and supportive care, and this may include specialist fetal care during pregnancy and intensive newborn care after delivery.
How many people live with Ephb4-related lymphatic-related hydrops fetalis?
Worldwide and U.S. prevalence estimates for EPHB4-related lymphatic-related hydrops fetalis are not consistently reported by a single authoritative source. Major rare-disease references describe it as extremely rare or list its frequency as unknown, so no reliable published count is available for either the world or the United States (MedlinePlus Genetics, 2024; Orphanet, 2024).
Overview
Ephb4-related lymphatic-related hydrops fetalisSymptoms
Ephb4-related lymphatic-related hydrops fetalis causes severe fluid buildup in a baby before birth, often around the lungs, heart, abdomen, or under the skin. Common signs include widespread swelling and breathing or heart problems that can be life-threatening.
Outlook and prognosis
Ephb4-related lymphatic-related hydrops fetalis can range from severe swelling before birth with pregnancy loss or newborn illness to milder cases that improve after delivery. Outlook depends on how much fluid builds up, which organs are affected, and whether symptoms continue later in childhood.
Causes and risk factors
Ephb4-related lymphatic-related hydrops fetalis is caused by a change in the EPHB4 gene, inherited from a parent or arising new in the baby. Family history raises risk, while other factors may affect severity rather than cause it.
Genetic influences
Genetics are central to Ephb4-related lymphatic-related hydrops fetalis. Changes in the EPHB4 gene are the main known cause, though the exact variant can affect how severe the condition is and how it appears in a family.
Diagnosis
Diagnosis of Ephb4-related lymphatic-related hydrops fetalis usually starts with ultrasound findings before birth, sometimes supported by family history. Genetic diagnosis of Ephb4-related lymphatic-related hydrops fetalis is confirmed with genetic testing, and imaging may help assess fluid buildup.
Treatment and drugs
Treatment for Ephb4-related lymphatic-related hydrops fetalis focuses on urgent pregnancy and newborn care, including close ultrasound monitoring, drainage of excess fluid when needed, and support for breathing or heart strain after birth. Genetic counseling and follow-up with fetal medicine, neonatology, and cardiology teams are often important.
Symptoms
Ephb4-related lymphatic-related hydrops fetalis often shows up before birth, when too much fluid builds up in a baby's tissues or around organs because the lymphatic system is not moving fluid normally. This can make a pregnancy high risk and, after birth, may lead to swelling, breathing trouble, or feeding difficulties. Features vary from child to child and can change over time. In some families, the early features of Ephb4-related lymphatic-related hydrops fetalis are first seen on prenatal ultrasound, while in others they become clearer around delivery or in infancy.
Before birth, fluid can build up under the skin and around the lungs, heart, or belly. This body-wide swelling is the main sign of Ephb4-related lymphatic-related hydrops fetalis and is often first seen on ultrasound.
Many babies have puffy skin, sometimes most noticeable in the face, scalp, hands, or feet. After birth, some swelling improves, but some children continue to have lymph-related swelling.
Fluid around the lungs can crowd the chest and keep the lungs from expanding fully. Newborns may breathe fast, grunt, or need oxygen and close monitoring.
Extra fluid in the abdomen can make the belly look swollen or tight. In a newborn, that can add pressure and make feeding and breathing harder.
How people usually first notice Ephb4-related lymphatic-related hydrops fetalis?
Ephb4-related lymphatic-related hydrops fetalis is often first noticed during pregnancy, when an ultrasound shows unusual fluid buildup in the baby’s body, such as swelling under the skin or around the lungs, heart, or abdomen. These first signs of Ephb4-related lymphatic-related hydrops fetalis may also include extra amniotic fluid, a thickened placenta, or a baby who looks more swollen than expected on prenatal imaging. After birth, if the condition is not already suspected, doctors may notice widespread swelling, breathing trouble, or signs that fluid is collecting where it should not be, which usually leads to urgent testing and specialist care.
Types of Ephb4-related lymphatic-related hydrops fetalis
No distinct types of Ephb4-related lymphatic-related hydrops fetalis are widely recognized.
Can I slow down the onset of symptoms?
No. For this rare inherited condition, there is no good evidence that diet, exercise, vitamins, or other lifestyle changes can meaningfully delay the start of symptoms, because the fluid buildup usually begins before birth from a change in a gene that affects how the baby's lymph vessels form, although research is still ongoing. What can help is early ultrasound monitoring and care from a high-risk pregnancy and genetics team, which may catch problems early and guide care, but this is not the same as preventing the condition.
What genetics can tell you about symptoms
Genetics can explain some of the wide range of symptoms in Ephb4-related lymphatic-related hydrops fetalis, but it usually cannot predict the exact course for one baby. Changes in the EPHB4 gene are linked to problems in how the lymphatic and blood vessel systems develop, which can lead to fluid buildup before birth, and in some families the same gene change may cause very severe illness in one pregnancy but milder swelling or vessel-related problems in another. This means genetic testing can help confirm the diagnosis and show that symptoms may vary in type, severity, and age of onset, but it often cannot say for certain how serious the condition will be.
Causes and risk factors
The main cause of EPHB4-related lymphatic-related hydrops fetalis is a change in the EPHB4 gene, which helps lymphatic and blood vessels form before birth. When this gene does not work as expected, fluid may not drain well and swelling can build up in the fetus. The gene change can be inherited from a parent, or it can happen for the first time in the baby, so family history can matter. Having this gene change does not mean a baby will definitely have the condition. There are no known lifestyle or environmental risk factors for EPHB4-related lymphatic-related hydrops fetalis, but differences in how the baby's lymphatic system develops can affect how severe it becomes.
What are the most common causes or risk factors?
The main cause of Ephb4-related lymphatic-related hydrops fetalis is a change in the EPHB4 gene, which can disturb how the body’s lymph vessels and blood vessels form before birth and lead to severe fluid buildup in the baby. In many families, this gene change is passed down from a parent, so the biggest risk factor is having a parent or close family member with an EPHB4-related condition, although it can also happen for the first time in a pregnancy. There are no well-known lifestyle, diet, or environmental risk factors for this condition.
Environmental and biological risk factors
For Ephb4-related lymphatic-related hydrops fetalis, there are no well-established environmental or non-genetic biological risk factors that have been clearly shown to raise the chance of it occurring. This is different from some other fetal conditions, where infections, maternal illness, or harmful exposures play a larger role. Awareness of both biological and environmental influences helps you feel prepared, but for this specific condition, those links have not been clearly proven.
Genetic risk factors
In Ephb4-related lymphatic-related hydrops fetalis, the main genetic cause is a harmful change in the EPHB4 gene, which helps the lymphatic system form and move fluid normally before birth. When this gene does not work properly, fluid can build up in a fetus and lead to hydrops. Some risk factors are inherited through our genes. In practice, the genetic causes of Ephb4-related lymphatic-related hydrops fetalis usually involve either a gene change passed down in a family or a new change that starts in the child.
EPHB4 change: A disease-causing change in the EPHB4 gene is the established cause of this condition. This gene is important for building and maintaining lymph vessels, so a harmful change can disrupt normal fluid drainage before birth.
Inherited change: In some families, the EPHB4 change is passed from a parent to a child. Usually, one altered copy is enough to raise the risk, so each pregnancy has a 1 in 2, or 50%, chance of inheriting the change.
New change: Sometimes the EPHB4 change appears for the first time in the baby and is not found in either parent. This is called a de novo change, and it can explain Ephb4-related lymphatic-related hydrops fetalis when there is no known family history.
Variable effects: People with the same EPHB4 change can have very different experiences. In one family, one person may have severe swelling before birth while another has mild findings or no obvious symptoms at all.
Family history: A family history of fetal hydrops, unexplained pregnancy losses, or lymphatic problems can be a clue to an inherited EPHB4 change. Even so, the pattern is not always obvious because the condition can affect relatives differently.
Parental mosaicism: Rarely, a parent may carry the gene change in only some of their cells, including egg or sperm cells. In that situation, blood testing in the parent may be normal, but there can still be a small chance of the condition happening again in another pregnancy.
Lifestyle risk factors
Ephb4-related lymphatic-related hydrops fetalis is not caused by lifestyle habits, because it results from an underlying genetic change affecting lymphatic development. Still, how lifestyle affects Ephb4-related lymphatic-related hydrops fetalis can matter during pregnancy by influencing placental function, fetal stress, and the chance of added complications. The most relevant factors are the mother's health behaviors during pregnancy, especially those that support close monitoring and reduce avoidable strain on the fetus.
Keeping regular prenatal visits can help hydrops and fetal fluid buildup be detected and tracked early. Earlier ultrasound follow-up may improve timing of referral, delivery planning, and supportive care.
Smoking or secondhand smoke can reduce oxygen delivery and worsen placental function during an already high-risk pregnancy. In a fetus with hydrops, this extra stress may increase the risk of poor growth or fetal compromise.
Alcohol does not cause this genetic condition, but it can add fetal stress and interfere with normal development. Avoiding alcohol helps limit extra risks on top of severe lymphatic disease and hydrops.
Non-prescribed drugs and substance misuse can impair placental blood flow or trigger pregnancy complications. That may worsen outcomes in pregnancies already affected by Ephb4-related lymphatic-related hydrops fetalis.
Risk prevention
For EPHB4-related lymphatic-related hydrops fetalis, there is usually no proven way to prevent the condition itself because it is linked to a change in a gene present from the start of pregnancy. Prevention mainly means lowering the chance of severe complications through early prenatal care, close monitoring, and planning with specialists. For families who have had an affected pregnancy before, genetic counseling can help clarify recurrence risk and discuss options for future pregnancies. Different people need different prevention strategies—there’s no single formula.
If EPHB4-related lymphatic-related hydrops fetalis has happened in your family, genetic counseling before or early in pregnancy can help estimate the chance of it happening again. It can also help families understand testing choices and reproductive options in a clear, practical way.
Testing parents or close relatives for an EPHB4 gene change may show whether the risk is inherited or happened for the first time. This information can guide planning for future pregnancies and help doctors choose the most useful prenatal tests.
Starting prenatal care early gives the best chance to spot fluid buildup and other warning signs before they become more severe. In families at higher risk, this can include targeted ultrasound and watching for early symptoms of hydrops fetalis during pregnancy.
A maternal-fetal medicine team can follow the pregnancy closely with repeat scans to check fluid around the baby, growth, and signs of strain on the heart or lungs. Prevention works best when combined with regular check-ups.
Can you prevent Ephb4-related lymphatic-related hydrops fetalis?
No, this condition usually cannot be prevented because it is most often linked to a change in a gene, not something a parent did or did not do during pregnancy. If it has happened in a family before, genetic counseling and testing may help clarify the chance in a future pregnancy and allow closer monitoring, but they cannot guarantee prevention. Good prenatal care is still important for overall pregnancy health.
Transmission
Ephb4-related lymphatic-related hydrops fetalis is not an infection, so it cannot be caught from another person through touch, breathing, food, or everyday contact. For families, the main question is how Ephb4-related lymphatic-related hydrops fetalis is inherited.
This condition is usually linked to a change in the EPHB4 gene, and in many families a parent with the gene change can pass it to a child in an autosomal dominant pattern, which means each pregnancy has a 1 in 2, or 50%, chance. In some babies, the gene change happens for the first time and is not inherited from either parent. Even within the same family, the effects can vary a lot, so one person may have mild swelling problems while another has severe fetal hydrops.
When to test your genes
Genetic testing is most useful if a pregnancy shows unexplained hydrops fetalis on ultrasound, especially with pleural effusions or edema, or if there is a family history of lymphatic problems, fetal loss, or recurrent hydrops. Identifying an EPHB4 variant can clarify the cause, guide pregnancy monitoring, and help with recurrence-risk counseling for future pregnancies.
Diagnosis
Ephb4-related lymphatic-related hydrops fetalis is usually diagnosed when a baby shows signs of abnormal fluid buildup before birth or at delivery, and doctors then look for the cause with imaging and genetic tests. In this condition, the lymphatic system, which helps move fluid through the body, does not develop or work as expected. Getting a diagnosis is often a turning point toward answers and support. Because fluid buildup in pregnancy can happen for several reasons, the diagnosis of Ephb4-related lymphatic-related hydrops fetalis often needs more than one step.
Ultrasound often gives the first clue by showing unusual fluid buildup in the fetus, such as swelling under the skin or fluid around the lungs, heart, or abdomen. These imaging findings can suggest hydrops fetalis and help doctors track how severe it is over time.
After birth, doctors examine the baby for swelling, breathing problems, or other signs linked to excess fluid and lymphatic problems. The pattern of features can help them decide whether a genetic condition such as Ephb4-related lymphatic-related hydrops fetalis is likely.
A blood sample from the baby, and sometimes from the parents, can be used to look for a change in the EPHB4 gene. This is the key test for the genetic diagnosis of Ephb4-related lymphatic-related hydrops fetalis and helps confirm the suspected cause.
A detailed family and health history can help because some conditions have a genetic link, meaning they can run in families. Doctors ask about earlier pregnancies, infant losses, unexplained swelling, or known lymphatic problems in relatives.
How is Ephb4-related lymphatic-related hydrops fetalis diagnosed?
Ephb4-related lymphatic-related hydrops fetalis is usually first suspected during pregnancy when an ultrasound shows too much fluid building up in the baby, such as swelling under the skin or fluid around the lungs, heart, or belly. Doctors then look for the cause with a detailed ultrasound, a heart scan for the baby, and tests to rule out other common reasons for hydrops fetalis, including chromosome problems and certain infections. The diagnosis is strongly supported, and often confirmed, by genetic testing that finds a harmful change in the EPHB4 gene.
Stages of Ephb4-related lymphatic-related hydrops fetalis
Ephb4-related lymphatic-related hydrops fetalis does not have defined progression stages. That is because it is usually recognized as a pattern of fluid buildup before birth rather than a condition that moves through clear step-by-step phases over time. Doctors usually start with a conversation about the pregnancy and use ultrasound to look for signs such as extra fluid in the baby’s tissues or around the lungs, heart, or abdomen; in some families, the early symptoms of Ephb4-related lymphatic-related hydrops fetalis are first picked up during a routine prenatal scan. Genetic testing may be offered to confirm a change in the EPHB4 gene, and follow-up imaging helps the care team monitor how severe the fluid buildup is and plan care during pregnancy and after delivery.
Outlook and prognosis
The outlook for Ephb4-related lymphatic-related hydrops fetalis is highly variable, but severe fetal hydrops is associated with a high risk of miscarriage, stillbirth, or death in the newborn period. Prognosis depends on how extensive the fluid accumulation is, whether there are complications such as pleural effusions or respiratory distress, and how early the condition is recognized and managed during pregnancy and after delivery. In some families, affected fetuses do not survive, while in others, infants who are treated successfully can live beyond the newborn period but may continue to have lymphatic problems such as lymphedema or recurrent fluid collections. Because pathogenic variants in EPHB4 can show variable expressivity, outcomes can differ even among relatives with the same genetic change. Long-term survivors generally need ongoing follow-up from genetics, cardiology, and lymphatic specialists to monitor for chronic complications and support development and overall health.
Long-term effects
For families affected by Ephb4-related lymphatic-related hydrops fetalis, the long-term picture can be very different from one child to another. Some pregnancies are severely affected before birth, while some babies who survive can go on to have ongoing lymphatic and fluid-balance problems after infancy. Long-term effects vary widely, and in some children the swelling improves over time, while in others it remains a chronic feature. Thinking about the long-term effects helps frame what doctors mean when they talk about prognosis in this condition.
The most serious long-term effect is that many pregnancies are lost before birth or shortly after delivery because the fluid buildup can be overwhelming. This means prognosis is often determined very early, even before the early symptoms of Ephb4-related lymphatic-related hydrops fetalis are fully understood.
Babies who survive may continue to have lymphedema, which is ongoing swelling caused by poor lymph drainage. This can affect the limbs, face, or genital area and may fluctuate over time rather than staying exactly the same.
Some children have repeated pleural effusions or chylothorax, meaning lymph-rich fluid collects around the lungs. Over time, this can lead to breathing problems, hospital stays, and a need for close follow-up in childhood.
Ongoing fluid retention in the body can remain a long-term feature, especially early in life. In some children it gradually lessens, while in others swelling and fluid shifts continue to be part of day-to-day health.
How is it to live with Ephb4-related lymphatic-related hydrops fetalis?
Living with EPHB4-related lymphatic-related hydrops fetalis can look very different from one family to another, but for many it begins with a high-risk pregnancy, frequent ultrasounds, and long stretches of uncertainty because the baby develops abnormal fluid buildup before birth. In the most severe cases, the condition can be life-threatening during pregnancy or shortly after delivery; in those who survive, ongoing care may involve monitoring for swelling, breathing or feeding difficulties, and other lymphatic problems that can affect daily routines and medical visits. For parents and loved ones, the impact is often emotional as well as practical, with repeated appointments, hospital care, and difficult decisions, so support from maternal-fetal medicine, neonatology, genetics, and counseling teams can make a meaningful difference.
Treatment and drugs
Treatment for Ephb4-related lymphatic-related hydrops fetalis depends on when it is found, how severe the fluid buildup is, and which parts of the body are affected. During pregnancy, care usually focuses on close monitoring with a high-risk obstetric team, planning delivery at a center with newborn intensive care, and sometimes procedures to drain extra fluid if it is putting the fetus at risk. After birth, babies may need help with breathing, drainage of fluid around the lungs or belly, and treatment for problems linked to the lymphatic system, such as swelling or ongoing fluid leakage. Treatment plans often combine several approaches, and many living with Ephb4-related lymphatic-related hydrops fetalis also benefit from follow-up with genetics, cardiology, and lymphatic specialists because there is no single medicine that fixes the underlying gene change.
Can you cure Ephb4-related lymphatic-related hydrops fetalis?
No. There is no cure yet for Ephb4-related lymphatic-related hydrops fetalis, a rare inherited condition that causes abnormal fluid buildup in a developing baby before birth. Treatment cannot fix the underlying genetic change, but it may help by closely monitoring the pregnancy and managing the fluid buildup and related problems with procedures before birth, early delivery if needed, and intensive newborn care after birth.
Non-drug treatment
Care usually centers on close monitoring and supportive care before and after birth, because Ephb4-related lymphatic-related hydrops fetalis can range from mild fluid buildup to life-threatening swelling. Treatment is tailored to where fluid is collecting, how the baby is growing, and whether breathing or heart function may be affected. Managing this condition often means care from a maternal-fetal medicine team, newborn specialists, and sometimes lymphatic experts. In some pregnancies, treatment for Ephb4-related lymphatic-related hydrops fetalis during pregnancy may include procedures to drain fluid or support delivery planning.
Frequent ultrasound scans help track fluid around the lungs, heart, abdomen, or skin and show how the baby is growing. Fetal echocardiography can check heart structure and function, since strain on the heart can worsen hydrops.
If fluid around the lungs or abdomen becomes severe, doctors may drain it with a needle to relieve pressure. This can sometimes help the lungs expand better or reduce stress on the heart before birth.
When chest fluid keeps coming back, a small tube may be placed to let fluid drain into the amniotic fluid. Not every approach works the same way, so this is usually reserved for selected pregnancies in specialized centers.
Careful planning for where and when birth happens can improve safety for both baby and parent. Many living with Ephb4-related lymphatic-related hydrops fetalis need delivery in a hospital with a neonatal intensive care unit and teams ready to support breathing right away.
Your genes may have an impact on how drugs work for you
For people living with Ephb4-related lymphatic hydrops fetalis, there is no well-established evidence that this genetic change predictably changes how the usual medicines work. In day-to-day care, treatment is mostly focused on the baby’s fluid buildup and breathing or heart support, and how well treatment helps usually depends more on how severe the swelling is and which body systems are affected than on a known medicine-response effect of the gene itself. This means the gene is very important in causing the condition, but it is not currently used in a routine, proven way to choose or adjust medicines for most families.
Pharmacological treatments
For Ephb4-related lymphatic-related hydrops fetalis, there is no medicine proven to correct the underlying genetic change. Treatment usually focuses on managing severe fluid buildup and supporting the heart and lungs, often in a high-risk pregnancy unit or neonatal intensive care unit. Some babies need medicines only for a short time around birth, while others need ongoing support if swelling, breathing trouble, or heart strain continues. The best drug plan depends on how severe the fluid buildup is and whether early symptoms of Ephb4-related lymphatic-related hydrops fetalis are seen before or after delivery.
There is no established disease-specific medication that reverses Ephb4-related lymphatic-related hydrops fetalis. Drug treatments are supportive and are chosen based on the complications a baby develops.
Medicines such as furosemide, and sometimes spironolactone, may be used to help remove extra fluid when swelling or fluid around the lungs is causing problems. These drugs need close monitoring because they can affect salts, kidney function, and blood pressure.
If Ephb4-related lymphatic-related hydrops fetalis leads to poor circulation or heart strain, intensive care teams may use drugs such as dopamine, dobutamine, or milrinone. These medicines help the heart pump more effectively and support blood flow while the baby is being stabilized.
Albumin infusions are sometimes used when there is severe fluid shift and very low blood protein levels. They are usually given with careful monitoring, often alongside a diuretic, because the effect can be temporary.
Genetic influences
When this condition is found during pregnancy, the cause is usually a change in the EPHB4 gene, which helps the body build and maintain lymphatic and blood vessels. In EPHB4-related lymphatic-related hydrops fetalis, that gene change can interfere with normal fluid drainage, leading to the severe fluid buildup seen before birth. It is usually inherited in a dominant pattern, meaning one altered copy of the gene can be enough to cause the condition, although the change can also happen for the first time in that pregnancy. Even with the same gene change, people can have very different effects, from severe hydrops in one pregnancy to much milder swelling or blood vessel findings in another relative. Genetic testing and counseling can help families understand the genetic cause of hydrops fetalis, the chance it could happen again, and whether other relatives may benefit from evaluation.
Is Ephb4-related lymphatic-related hydrops fetalis genetic?
Genetics are central to Ephb4-related lymphatic-related hydrops fetalis. Changes in the EPHB4 gene are the main known cause, though the exact variant can affect how severe the condition is and how it appears in a family.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a normal part of being human and are widely found in the general population. Most of these variants do not have a direct effect on health and simply reflect natural human diversity. For many genes, having a variant associated with a condition points to a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some cases, though, a single well-understood variant in a specific gene is enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
In Ephb4-related lymphatic-related hydrops fetalis, finding a change in the EPHB4 gene mainly helps doctors understand why severe fluid buildup is happening and plan care quickly before and after birth. The genetic result can guide decisions about monitoring, delivery planning, and supportive treatment for problems such as extra fluid, breathing trouble, or stress on the heart. There is no proven medicine that directly fixes the EPHB4 change itself, so treatment is usually aimed at the complications the condition causes rather than the gene variant. Genetics is only one factor, and the drugs a baby may receive are usually chosen based on symptoms, gestational age, weight, and how well the lungs, heart, and other organs are working. In some families, genetic testing also helps with testing parents and planning future pregnancies, which can lead to earlier recognition and care. If you are looking into how genetics affect treatment for Ephb4-related lymphatic-related hydrops fetalis, the biggest impact right now is on diagnosis, monitoring, and care planning, not on matching someone to a specific medication.
Interactions with other conditions
For families, this condition often shows up in the setting of pregnancy complications, where severe fluid buildup in the baby can also happen for other reasons and may be hard to sort out at first. Ephb4-related lymphatic-related hydrops fetalis can overlap with heart problems, blood disorders, infections, and chromosome conditions that also cause hydrops, so doctors usually look carefully for more than one possible cause. Doctors call it a comorbidity when two conditions occur together. In some babies, changes in the lymphatic system are the main issue, while in others an additional problem, such as a structural heart defect, can make the swelling and breathing problems around birth more severe. This is one reason the early symptoms of Ephb4-related lymphatic-related hydrops fetalis are often assessed alongside testing for anemia, fetal infection, and genetic conditions with similar features. Interactions can look very different from person to person, so care often involves both genetics and fetal or newborn specialists to understand whether another disease is also contributing.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Ephb4-related lymphatic-related hydrops fetalis?
Similar severe fluid buildup before birth can also be caused by blood group incompatibility between mother and baby, heart problems, severe anemia, certain infections, changes in chromosomes such as Turner syndrome, and other inherited conditions that affect the lymph vessels, including some forms of Noonan syndrome. Because many different problems can look this way on prenatal scans, doctors usually need heart, blood, infection, and genetic testing to tell them apart.
History
Long before doctors could explain why it happened, they described babies with severe, widespread swelling before birth or at delivery. Older medical reports used the broad term hydrops fetalis for this pattern, but for many years it was grouped together with many different conditions that can look similar. In recent decades, awareness has grown that some forms of hydrops fetalis are linked to problems in how the lymphatic system develops, rather than to blood-group incompatibility or infection alone.
As ultrasound became part of routine prenatal care in the late 20th century, doctors could see fluid building up during pregnancy instead of only recognizing it after birth. That changed the history of the condition in a very practical way. Families and care teams could sometimes learn earlier that a fetus had skin swelling, fluid around the lungs or heart, or other signs that pointed to hydrops, which helped shape monitoring, delivery plans, and newborn care.
Over time, specialists began to notice that not all cases followed the same course. Some pregnancies were affected very severely, while others showed milder findings or a different pattern of lymphatic swelling. This helped move medicine away from treating hydrops fetalis as a single disease and toward understanding it as a sign with several possible causes, including rare inherited conditions.
That shift set the stage for what is now called Ephb4-related lymphatic-related hydrops fetalis. Researchers gradually recognized that this diagnosis belongs to a group of disorders in which the lymphatic vessels, the body’s fluid-drainage network, do not form or function in the usual way. Later genetic research confirmed that some families with recurrent or unexplained hydrops had an underlying genetic cause, allowing doctors to connect prenatal findings with a more specific diagnosis than was possible in earlier decades.
The history of Ephb4-related lymphatic-related hydrops fetalis is therefore closely tied to two bigger changes in medicine: better fetal imaging and better genetic testing. For families, that has meant fewer cases being left unexplained, even though this remains a rare condition and much is still learned from careful follow-up of each pregnancy. Knowing this history also helps explain why older records may use broader labels, while newer reports are more precise about lymphatic causes and the early symptoms of Ephb4-related lymphatic-related hydrops fetalis seen on prenatal scans.